Merrimack Pharmaceuticals, Inc.

Organization

Cambridge, MA, US

Ticker Symbols

NASDAQ:MACK

PHARMACEUTICAL PREPARATIONS
Business Address
ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
Mailing Address
ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
State Location
MA
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)
- Patent number 10,570,119
- Issue date Feb 25, 2020
- Merrimack Pharmaceuticals, Inc.
- Daryl C. Drummond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biomarker profiles for predicting outcomes of cancer therapy with E...
- Patent number 10,273,304
- Issue date Apr 30, 2019
- Merrimack Pharmaceuticals, Inc.
- Bambang Adiwijaya
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Biomarkers for predicting outcomes of cancer therapy with ErbB3 inh...
- Patent number 10,184,006
- Issue date Jan 22, 2019
- Merrimack Pharmaceuticals, Inc.
- Olga Burenkova
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for delivering nucleic acid to a cell
- Patent number 10,087,464
- Issue date Oct 2, 2018
- Merrimack Pharmaceuticals, Inc.
- Mark E. Hayes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against epidermal growth factor receptor (EGFR) and uses...
- Patent number 10,072,299
- Issue date Sep 11, 2018
- Merrimack Pharmaceuticals, Inc.
- Raghida Bukhalid
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bi-specific fusion proteins
- Patent number 9,982,060
- Issue date May 29, 2018
- Merrimack Pharmaceuticals, Inc.
- Ulrik Bjerl Nielsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for non-invasive imaging
- Patent number 9,968,694
- Issue date May 15, 2018
- Merrimack Pharmaceuticals, Inc.
- Daryl C. Drummond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies
- Patent number 9,938,346
- Issue date Apr 10, 2018
- Merrimack Pharmaceuticals, Inc.
- Jason Baum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosage and administration of anti-EGFR therapeutics
- Patent number 9,920,131
- Issue date Mar 20, 2018
- Merrimack Pharmaceuticals, Inc.
- Jeffrey David Kearns
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy for treating HER2-positive cancers
- Patent number 9,913,901
- Issue date Mar 13, 2018
- Merrimack Pharmaceuticals, Inc.
- Victor Moyo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against epidermal growth factor receptor (EGFR) and uses...
- Patent number 9,902,999
- Issue date Feb 27, 2018
- Merrimack Pharmaceuticals, Inc.
- Raghida Bukhalid
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against epidermal growth factor receptor (EGFR) and uses...
- Patent number 9,885,087
- Issue date Feb 6, 2018
- Merrimack Pharmaceuticals, Inc.
- Raghida Bukhalid
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating myocardial infarction by administering a bi-spec...
- Patent number 9,718,892
- Issue date Aug 1, 2017
- Merrimack Pharmaceuticals, Inc.
- Ulrik Nielsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biomarker profiles for predicting outcomes of cancer therapy with E...
- Patent number 9,688,761
- Issue date Jun 27, 2017
- Merrimack Pharmaceuticals, Inc.
- Bambang Adiwijaya
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Dosage and administration of anti-EGFR therapeutics
- Patent number 9,657,108
- Issue date May 23, 2017
- Merrimack Pharmaceuticals, Inc.
- Jeffrey David Kearns
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosage and administration for preventing cardiotoxicity in treatmen...
- Patent number 9,610,249
- Issue date Apr 4, 2017
- Merrimack Pharmaceuticals. Inc.
- Joseph G. Reynolds
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodies
- Patent number 9,556,274
- Issue date Jan 31, 2017
- Merrimack Pharmaceuticals, Inc.
- Jason Baum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies
- Patent number 9,527,914
- Issue date Dec 27, 2016
- Merrimack Pharmaceuticals, Inc.
- Jason Baum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of ERBB3 inhibitors in the treatment of triple negative and bas...
- Patent number 9,518,130
- Issue date Dec 13, 2016
- Merrimack Pharmaceuticals, Inc.
- Victor Moyo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for non-invasive imaging
- Patent number 9,511,155
- Issue date Dec 6, 2016
- Merrimack Pharmaceuticals, Inc.
- Daryl C. Drummond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating pancreatic cancer using combination therapies...
- Patent number 9,492,442
- Issue date Nov 15, 2016
- Merrimack Pharmaceuticals, Inc.
- Eliel Bayever
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against the ectodomain of ERBB3 and uses thereof
- Patent number 9,487,588
- Issue date Nov 8, 2016
- Merrimack Pharmaceuticals, Inc.
- Birgit Schoeberl
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ANTI-C-MET tandem Fc bispecific antibodies
- Patent number 9,458,245
- Issue date Oct 4, 2016
- Merrimack Pharmaceuticals, Inc.
- Brian Harms
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating pancreatic cancer using combination therapies...
- Patent number 9,452,162
- Issue date Sep 27, 2016
- Merrimack Pharmaceuticals, Inc.
- Eliel Bayever
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating pancreatic cancer using combination therapies...
- Patent number 9,364,473
- Issue date Jun 14, 2016
- Merrimack Pharmaceuticals, Inc.
- Eliel Bayever
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapies comprising anti-ERBB3 agents
- Patent number 9,345,766
- Issue date May 24, 2016
- Merrimack Pharmaceuticals, Inc.
- Bo Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating pancreatic cancer using combination therapies...
- Patent number 9,339,497
- Issue date May 17, 2016
- Merrimack Pharmaceuticals, Inc.
- Eliel Bayever
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bi-specific fusion proteins
- Patent number 9,238,080
- Issue date Jan 19, 2016
- Merrimack Pharmaceuticals, Inc.
- Ulrik Nielsen
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Antibodies against epidermal growth factor receptor (EGFR) and uses...
- Patent number 9,226,964
- Issue date Jan 5, 2016
- Merrimack Pharmaceuticals, Inc.
- Raghida Bukhalid
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosage and administration for preventing cardiotoxicity in treatmen...
- Patent number 9,226,966
- Issue date Jan 5, 2016
- Merrimack Pharmaceuticals, Inc.
- Joseph G. Reynolds
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
ANTI-TNFR2 ANTIBODIES AND USES THEREOF
- Publication number 20220281990
- Publication date Sep 8, 2022
- Merrimack Pharmaceuticals, Inc.
- Yu ZHOU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TNFR2 ANTIBODIES AND USES THEREOF
- Publication number 20210371537
- Publication date Dec 2, 2021
- Merrimack Pharmaceuticals, Inc.
- Eric M. TAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nanoliposomal Targeting of Ephrin Receptor A2 (Epha2) and Related D...
- Publication number 20190298681
- Publication date Oct 3, 2019
- Merrimack Pharmaceuticals, Inc.
- Daryl C. Drummond
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF
- Publication number 20190292271
- Publication date Sep 26, 2019
- Merrimack Pharmaceuticals, Inc.
- Birgit M. SCHOEBERL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR SELECTING AND TREATING PATIENTS WITH A TRAIL-BASED THER...
- Publication number 20190185541
- Publication date Jun 20, 2019
- Merrimack Pharmaceuticals, Inc.
- Tamara DAKE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR)
- Publication number 20190135789
- Publication date May 9, 2019
- Merrimack Pharmaceuticals, Inc.
- Daryl C. Drummond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BAS...
- Publication number 20190119401
- Publication date Apr 25, 2019
- Merrimack Pharmaceuticals, Inc.
- Victor MOYO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING ER+, HER2-, HRG+ BREAST CANCER USING COMBINATI...
- Publication number 20190091227
- Publication date Mar 28, 2019
- Merrimack Pharmaceuticals, Inc.
- Akos CZIBERE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENGINEERED TRAIL FOR CANCER THERAPY
- Publication number 20190077870
- Publication date Mar 14, 2019
- Merrimack Pharmaceuticals, Inc.
- Diana Hung-yi Chai MARCANTONIO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treating Ephrin Receptor A2 (Epha2) Positive Cancer with Targeted D...
- Publication number 20190070113
- Publication date Mar 7, 2019
- Merrimack Pharmaceuticals, Inc.
- Daryl C. Drummond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACID TO A CELL
- Publication number 20190017073
- Publication date Jan 17, 2019
- MERRIMACK PHARMACEUTICALS
- Mark Eamon Hayes
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DISULFIDE-STABILIZED FABS
- Publication number 20180271998
- Publication date Sep 27, 2018
- Merrimack Pharmaceuticals, Inc.
- Daryl C. DRUMMOND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-FGFR ANTIBODIES AND METHODS OF USE
- Publication number 20180244785
- Publication date Aug 30, 2018
- Merrimack Pharmaceuticals, Inc.
- Tamara DAKE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bi-Specific Fusion Proteins
- Publication number 20180237540
- Publication date Aug 23, 2018
- Merrimack Pharmaceuticals, Inc.
- Ulrik Bjerl Nielsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION CANCER THERAPIES
- Publication number 20180169230
- Publication date Jun 21, 2018
- Merrimack Pharmaceuticals, Inc.
- Sharlene ADAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS
- Publication number 20180066065
- Publication date Mar 8, 2018
- Merrimack Pharmaceuticals, Inc.
- Bo ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE AND ADMINISTRATION OF MONOSPECIFIC AND BISPECIFIC ANTI-IGR-1...
- Publication number 20180036395
- Publication date Feb 8, 2018
- Merrimack Pharmaceuticals, Inc.
- Alexey Alexandrovich LUGOVSKOY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ephrin Receptor A2 (EPHA2)-Targeted Docetaxel-Generating Nano-Lipos...
- Publication number 20180021294
- Publication date Jan 25, 2018
- Merrimack Pharmaceuticals, Inc.
- Daryl C. Drummond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL AND OLIGOCLONAL ANTI-EGFR ANTIBODIES FOR USE IN THE TREA...
- Publication number 20170356049
- Publication date Dec 14, 2017
- Merrimack Pharmaceuticals, Inc.
- Raghida BUKHALID
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Non-Invasive Imaging Methods for Patient Selection for Treatment wi...
- Publication number 20170340656
- Publication date Nov 30, 2017
- Merrimack Pharmaceuticals, Inc.
- Daryl C. Drummond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bi-Specific Fusion Proteins
- Publication number 20170335015
- Publication date Nov 23, 2017
- Merrimack Pharmaceuticals, Inc.
- Ulrik Nielsen
- B82 - NANO-TECHNOLOGY
Information Patent Application
CARTILAGE-BINDING FUSION PROTEINS
- Publication number 20170327556
- Publication date Nov 16, 2017
- Merrimack Pharmaceuticals, Inc.
- Emily FLORINE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES...
- Publication number 20170314079
- Publication date Nov 2, 2017
- Merrimack Pharmaceuticals, Inc.
- Raghida BUKHALID
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS, SYSTEMS AND PRODUCTS FOR PREDICTING RESPONSE OF TUMOR CELL...
- Publication number 20170307631
- Publication date Oct 26, 2017
- Merrimack Pharmaceuticals, Inc.
- Birgit SCHOEBERL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BAS...
- Publication number 20170291957
- Publication date Oct 12, 2017
- Merrimack Pharmaceuticals, Inc.
- Victor MOYO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKER PROFILES FOR PREDICTING OUTCOMES OF CANCER THERAPY WITH E...
- Publication number 20170267767
- Publication date Sep 21, 2017
- Merrimack Pharmaceuticals, Inc.
- Bambang ADIWIJAYA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Protein A Binding Polypeptides, Anti-EphA2 Antibodies and Methods o...
- Publication number 20170267768
- Publication date Sep 21, 2017
- The Regents of the University of California
- James D. Marks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DOSAGE AND ADMINISTRATION OF ANTI-EGFR THERAPEUTICS
- Publication number 20170267779
- Publication date Sep 21, 2017
- Merrimack Pharmaceuticals, Inc.
- Jeffrey David KEARNS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES FOR TREATING HER2-POSITIVE CANCERS THAT ARE R...
- Publication number 20170258903
- Publication date Sep 14, 2017
- Merrimack Pharmaceuticals, Inc.
- Christopher W. Espelin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE AND ADMINISTRATION OF ANTI-EGFR THERAPEUTICS
- Publication number 20170253662
- Publication date Sep 7, 2017
- Merrimack Pharmaceuticals, Inc.
- Jeffrey David KEARNS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
87643544 - M
- Serial number 87643544
- Filing date Oct 12, 2017
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87527007 - OTABLI
- Serial number 87527007
- Filing date Jul 13, 2017
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87527012 - EMORYST
- Serial number 87527012
- Filing date Jul 13, 2017
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87526994 - CAVLIRI
- Serial number 87526994
- Filing date Jul 13, 2017
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87526999 - KICELZA
- Serial number 87526999
- Filing date Jul 13, 2017
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86728845 - PROVYDE
- Serial number 86728845
- Registration number 4955106
- Filing date Aug 18, 2015
- Merrimack Pharmaceuticals, Inc.
- 35 - Advertising
Information Trademark
86728856 - PROVYDE
- Serial number 86728856
- Registration number 4955108
- Filing date Aug 18, 2015
- Merrimack Pharmaceuticals, Inc.
- 35 - Advertising
Information Trademark
86725349 - M
- Serial number 86725349
- Filing date Aug 14, 2015
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86979330 - CANCER IS THE ULTIMATE ENGINEERING CHALLENGE
- Serial number 86979330
- Registration number 5079819
- Filing date Aug 14, 2015
- Merrimack Pharmaceuticals, Inc.
- 16 - Paper, cardboard and goods made from these materials, not included in other classes
Information Trademark
86725528
- Serial number 86725528
- Registration number 5198004
- Filing date Aug 14, 2015
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86725319 - M
- Serial number 86725319
- Registration number 5125281
- Filing date Aug 14, 2015
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86725362 - CANCER IS THE ULTIMATE ENGINEERING CHALLENGE
- Serial number 86725362
- Filing date Aug 14, 2015
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86725197 - MERRIMACK
- Serial number 86725197
- Registration number 5092385
- Filing date Aug 14, 2015
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86725339 - M
- Serial number 86725339
- Filing date Aug 14, 2015
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86725203 - MERRIMACK PHARMACEUTICALS
- Serial number 86725203
- Registration number 5125280
- Filing date Aug 14, 2015
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85971092 - EMORYST
- Serial number 85971092
- Filing date Jun 26, 2013
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85971097 - ONIVYDE
- Serial number 85971097
- Registration number 4874816
- Filing date Jun 26, 2013
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85971090 - CAVLIRI
- Serial number 85971090
- Filing date Jun 26, 2013
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85971099 - KICELZA
- Serial number 85971099
- Filing date Jun 26, 2013
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85971102 - OTABLI
- Serial number 85971102
- Filing date Jun 26, 2013
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85621415 - LIPOSIMILAR
- Serial number 85621415
- Filing date May 10, 2012
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
85621532 - NANOSIMILAR
- Serial number 85621532
- Filing date May 10, 2012
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76977678 - M
- Serial number 76977678
- Registration number 2998835
- Filing date Sep 12, 2003
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76544840 - NETWORK BIOLOGY
- Serial number 76544840
- Filing date Sep 12, 2003
- Merrimack Pharmaceuticals, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
76544846 - M MERRIMACK PHARMACEUTICALS
- Serial number 76544846
- Registration number 3004786
- Filing date Sep 12, 2003
- Merrimack Pharmaceuticals, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
76544841 - M
- Serial number 76544841
- Filing date Sep 12, 2003
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76544845 - M MERRIMACK PHARMACEUTICALS
- Serial number 76544845
- Filing date Sep 12, 2003
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76977673 - M MERRIMACK PHARMACEUTICALS
- Serial number 76977673
- Registration number 3004863
- Filing date Sep 12, 2003
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
76544842 - M
- Serial number 76544842
- Registration number 3004784
- Filing date Sep 12, 2003
- Merrimack Pharmaceuticals, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
76544843 - M MERRIMACK
- Serial number 76544843
- Filing date Sep 12, 2003
- Merrimack Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations

NIH Research Projectlast 12 months

processing...

Count: 5

Research Projects

Information Research Project
Antibody Microarrays for Cancer Diagnostics
- Application id 7253255
- Award notice date Jun 7, 2007
Information Research Project
Antibody Microarrays for Cancer Diagnostics
- Application id 7051294
- Award notice date Jul 1, 2006
Information Research Project
Predicting Molecular Responses to ErbB inhibitors
- Application id 6879367
- Award notice date Aug 26, 2005
Information Research Project
Production of Antibodies Suitable for Microarrays
- Application id 6735301
- Award notice date Mar 1, 2004
Information Research Project
Protein Microarrays in Cancer Drug Discovery
- Application id 6722489
- Award notice date Jan 22, 2004

Merrimack Pharmaceuticals, Inc.

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)

Biomarker profiles for predicting outcomes of cancer therapy with E...

Biomarkers for predicting outcomes of cancer therapy with ErbB3 inh...

Compositions and methods for delivering nucleic acid to a cell

Antibodies against epidermal growth factor receptor (EGFR) and uses...

Bi-specific fusion proteins

Compositions and methods for non-invasive imaging

Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies

Dosage and administration of anti-EGFR therapeutics

Combination therapy for treating HER2-positive cancers

Antibodies against epidermal growth factor receptor (EGFR) and uses...

Antibodies against epidermal growth factor receptor (EGFR) and uses...

Method of treating myocardial infarction by administering a bi-spec...

Biomarker profiles for predicting outcomes of cancer therapy with E...

Dosage and administration of anti-EGFR therapeutics

Dosage and administration for preventing cardiotoxicity in treatmen...

Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodies

Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies

Use of ERBB3 inhibitors in the treatment of triple negative and bas...

Compositions and methods for non-invasive imaging

Methods for treating pancreatic cancer using combination therapies...

Antibodies against the ectodomain of ERBB3 and uses thereof

ANTI-C-MET tandem Fc bispecific antibodies

Methods for treating pancreatic cancer using combination therapies...

Methods for treating pancreatic cancer using combination therapies...

Combination therapies comprising anti-ERBB3 agents

Methods for treating pancreatic cancer using combination therapies...

Bi-specific fusion proteins

Antibodies against epidermal growth factor receptor (EGFR) and uses...

Dosage and administration for preventing cardiotoxicity in treatmen...

Patents Applicationslast 30 patents

ANTI-TNFR2 ANTIBODIES AND USES THEREOF

ANTI-TNFR2 ANTIBODIES AND USES THEREOF

Nanoliposomal Targeting of Ephrin Receptor A2 (Epha2) and Related D...

ANTIBODIES AGAINST THE ECTODOMAIN OF ERBB3 AND USES THEREOF

METHODS FOR SELECTING AND TREATING PATIENTS WITH A TRAIL-BASED THER...

INHIBITING ATAXIA TELANGIECTASIA AND RAD3-RELATED PROTEIN (ATR)

USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BAS...

METHODS FOR TREATING ER+, HER2-, HRG+ BREAST CANCER USING COMBINATI...

ENGINEERED TRAIL FOR CANCER THERAPY

Treating Ephrin Receptor A2 (Epha2) Positive Cancer with Targeted D...

COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACID TO A CELL

DISULFIDE-STABILIZED FABS

ANTI-FGFR ANTIBODIES AND METHODS OF USE

Bi-Specific Fusion Proteins

COMBINATION CANCER THERAPIES

COMBINATION THERAPIES COMPRISING ANTI-ERBB3 AGENTS

DOSAGE AND ADMINISTRATION OF MONOSPECIFIC AND BISPECIFIC ANTI-IGR-1...

Ephrin Receptor A2 (EPHA2)-Targeted Docetaxel-Generating Nano-Lipos...

MONOCLONAL AND OLIGOCLONAL ANTI-EGFR ANTIBODIES FOR USE IN THE TREA...

Non-Invasive Imaging Methods for Patient Selection for Treatment wi...

Bi-Specific Fusion Proteins

CARTILAGE-BINDING FUSION PROTEINS

ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES...

METHODS, SYSTEMS AND PRODUCTS FOR PREDICTING RESPONSE OF TUMOR CELL...

USE OF ERBB3 INHIBITORS IN THE TREATMENT OF TRIPLE NEGATIVE AND BAS...

BIOMARKER PROFILES FOR PREDICTING OUTCOMES OF CANCER THERAPY WITH E...

Protein A Binding Polypeptides, Anti-EphA2 Antibodies and Methods o...

DOSAGE AND ADMINISTRATION OF ANTI-EGFR THERAPEUTICS

COMBINATION THERAPIES FOR TREATING HER2-POSITIVE CANCERS THAT ARE R...

DOSAGE AND ADMINISTRATION OF ANTI-EGFR THERAPEUTICS

Trademarklast 30 trademarks

87643544 - M

87527007 - OTABLI

87527012 - EMORYST

87526994 - CAVLIRI

87526999 - KICELZA

86728845 - PROVYDE

86728856 - PROVYDE

86725349 - M

86979330 - CANCER IS THE ULTIMATE ENGINEERING CHALLENGE

86725528